Titlebook: Supportive Care in Cancer Therapy; David S. Ettinger Book 20091st edition Humana Press 2009 Anorexia.Cachexia.Depression.Dyspnea.Fatigue.N

Biguanides

FLORA

STRIA

外貌

变量

为宠爱

Oral Mucositis,mple of other agents in development for which efficacy is based on disruption of the biological pathways leading to mucositis. This chapter discusses the clinical characteristics of mucositis, how it is evaluated and scored, its pathogenesis, and current and evolving prevention and treatment strategies.

DEMN

Neutropenia,the current guidelines for use. Lastly, while the focus will be predominantly around support for chemotherapy-induced neutropenia, the impact of myeloid growth factors in other settings, including high-dose chemotherapy and the management of chronic neutropenia will also be briefly addressed.

AGGER

Book 20091st editionlated to the cancer and/or its treatment; physical, psychosocial and emotional issues associated with the cancer. Patients with cancer, in general, are living longer. Even those with advanced, metastatic disease have an increase in their survival. This, in part, is due to better therapies, novel tre

无法治愈

Management of Dyspnea, in the context of a patient’s goals of care. Although invasive and pharmacologic interventions can be useful in many patients, because dyspnea is a subjective phenomenon, psychosocial/spiritual support is needed in all patients.

手术刀

Pathogenesis and Management of Venous Thromboembolism in Cancer Patients,) The epidemiology of VTE in cancer patients, (2) The pathogenesis of cancer-related thrombosis, (3) The prevention and treatment of VTE in the cancer patient, and (4) Special topics in VTE management including management of recurrent VTE and heparin-induced thrombocytopenia.